- Additional Authors
- Center for Biologics Evaluation and Research (U.S.)
- Description
- i, 4 pages : digital, PDF file
- Alternative Title
- Amendment (donor deferral for transfusion in France since 1980) to "Guidance for industry, revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products"
- Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vDJD) by blood and blood products
- Subject
- Note
- Title from PDF title page (viewed on May 18, 2009).
- "Draft guidance."
- "August 2006".
- Bibliography (note)
- Includes bibliographical references (page 4).
- System Details (note)
- Mode of access: Internet at the FDA CBER web site. Address as of 5/18/09: http://www.fda.gov/cber/gdlns/cjdfrance.pdf ; current access is available via PURL.
- Call Number
- GPO Internet HE 20.4802:D 71/3
- OCLC
- marcive325125165
- Title
Guidance for industry : amendment (donor deferral for transfusion in France since 1980) to "Guidance for industry, revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products"
- Publisher
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]
- Type of Content
text
- Type of Medium
computer
- Type of Carrier
online resource
- System Details
Mode of access: Internet at the FDA CBER web site. Address as of 5/18/09: http://www.fda.gov/cber/gdlns/cjdfrance.pdf ; current access is available via PURL.
- Bibliography
Includes bibliographical references (page 4).
- Connect to:
- Added Author
Center for Biologics Evaluation and Research (U.S.)
- Gpo Item No.
0499-T-02 (online)
- Sudoc No.
HE 20.4802:D 71/3